Researchers report on a class of rhodanine and thiobarbituric derivatives displaying a broad spectrum antiviral activity against seven different enveloped viruses including an HSV-2 acyclovir resistant strain with favorable selectivity indexes.
7th December 2018 •
comment
Submit an article
We welcome contributions from members. Please submit an article for review by our editorial team.
Upload nowCategories
- Arbovirus (5)
- Articles (1)
- Asia (1)
- biomedical research (1)
- Brazil (Mesh) (1)
- Chikungunya (5)
- Child Health (1)
- Clinical Trial Laboratories (2)
- Clinical trials (1)
- Cohort studies (1)
- Communication (1)
- Communications (Mesh) (1)
- Community Engagement (2)
- Coronavirus (7)
- COVID-19 (WEPHREN Resources) (1)
- Data Analysis (1)
- Data Management (1)
- Data Management and Statistics (3)
- Disease-specific Guidance (8)
- Empirical ethics (1)
- Epidemics (1)
- Ethics and Engagement (1)
- Ethics and Informed Consent (5)
- Funding (2)
- Global Health (2)
- Global Health Research Ethics (1)
- GPP - social & political (1)
- Health Inequality (5)
- Infectious diseases (7)
- Latest Publications (8)
- Latin America (10)
- Maternal/Fetal health during pregnancy (2)
- Maternal Health (1)
- Maternal & Infant Health (6)
- Microbiology (1)
- Neonatal period (1)
- North America (1)
- Nutrition (1)
- Operational/Governance (1)
- Pandemic preparedness (3)
- Pediatric (1)
- Post-marketing surveillance (1)
- Press Release (1)
- Project Report (1)
- Publications (164)
- Regulations and Guidelines (2)
- Reports (2)
- Resources (8)
- social protection (1)
- SOP (1)
- Study Protocols (1)
- Test Evaluations (1)
- Tests (2)
- Traditional medicine safety (1)
- Training (10)
- Trial Design (3)
- Trial Management (10)
- Trial Operations (13)
- universal health coverage (1)
- Vacccine Production (1)
- Vaccine Efficacy (2)
- Vaccine safety (2)
- Webinar (1)
- Women's Health (1)
- Workshops (1)
- zika (9)
- zika (mesh) (1)